Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 60,000 shares at $28.24 ($1.7M) on 2011-04-18, disclosed to the SEC on 2011-04-19.
Scheduled sale ($1.7M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |